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Abstract Several neurodegenerative diseases are caused by
expansion of polyglutamine repeats in the affected proteins. In
spino-cerebellar ataxia type 1 (SCA1), histidine interruptions
have been reported to mitigate the pathological effects of long
glutamine stretches. To understand this phenomenon, we
investigated the conformational preferences of peptides contain-
ing both the uninterrupted polyglutamine stretches and those with
histidine interruption(s) as seen in SCA1 normals. Our study
suggests that substitution of histidines by glutamines induces a
conformational change which results in decreased solubility and
increased aggregation. Our findings also suggest that all the
polyglutamine peptides with and without interruption(s) adopt a
L-structure and not random coil.
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1. Introduction
Polyglutamine expansions are known to be the cause of at
least eight neurodegenerative disorders [1^3]. The expanded
polyglutamines are thought to form potentially toxic intranu-
clear inclusions within the neurons, leading to cell death and
subsequent neurodegeneration [4,5]. It has been proposed that
these repeats might have a L-helical structure [6] related to
that suggested for amyloid ¢brils and prion particles [7,8].
However, a random coil conformation has also been sug-
gested by Altschuler et al. for oligoglutamines having 9 and
17 glutamine repeats [9].
In all the diseases caused by polyglutamine expansions, the
glutamine stretch is encoded by the CAG codon. In case of
one of the disease loci, spino-cerebellar ataxia type 1 (SCA1),
the CAG repeat stretch is interrupted approximately in the
middle by CAT, which encodes histidine [10,11]. The range
of repeats observed in normal individuals in SCA1 is 19^36,
while mutant proteins carry 40^81 repeats [10,11]. Most of the
normal proteins (93%) in SCA1 carry glutamine repeats inter-
rupted by 1^2 histidine residues having a con¢guration of
(Gln)n-His-Gln-His-(Gln)n. However, mutant proteins carry
expanded repeats which have lost the His interruptions [11].
Thus, in the case of SCA1, the pathological allele di¡ers both
at the protein and DNA level, not only in repeat length but
also in the con¢guration of the repeat stretch. It is known that
at the DNA level, long stretches of CAGs are stabilised by
non-CAG interruptions [11^13]. Do these interruptions also
play a role at the protein level? Quan et al. [14] have reported
an SCA1 allele with 44 repeats, which was transmitted stabily.
The repeat length is well within the disease range for SCA1,
however, the individual was normal. On sequencing, it was
found that the glutamine repeat was interrupted twice by
His-Gln-His con¢guration and was of the form (CAG)12
CAT CAG CAT (CAG)12 CAT CAG CAT (CAG)14 and 21
CAG repeats encoding glutamine was the longest uninter-
rupted tract seen in normal alleles in SCA1 [14]. Thus,
although the number of glutamines was within the disease
range, their pathological e¡ect seemed to be mitigated by
the presence of non-glutamine interruptions. Since the patho-
logical mechanism in SCA1 is thought to be mediated by
aggregation, we have studied the e¡ect of non-glutamine in-
terruptions on the conformation and aggregation properties
of polyglutamine stretches. Biophysical studies were carried
out on peptides with a sequence similar to that of polyglut-
amine stretches observed in normal and uninterrupted SCA1
proteins. Results reported here show that His interruption
within polyglutamine tracts, as observed in normal SCA1 pro-
teins, reduces their potential to aggregate.
2. Materials and methods
2.1. Design and solid phase synthesis of peptides
Polyglutamine peptides were designed and synthesised with His
interruptions (Q8HQHQ8 and Q10HQHQ10) as observed in the case
of normal SCA1 protein. Although mutant SCA1 proteins have more
than 40 glutamines, due to solubility reasons, Q22 was used as a model
peptide for an uninterrupted polyglutamine stretch. Also, no normal
SCA1 protein has been reported with more than 21 uninterrupted
glutamine repeats [14]. Further, to study the e¡ect, if any, of the
number of glutamines present between the two histidine interruptions
in the normal SCA1 protein, an analogue having four glutamines
between the histidines (Q8HQ4HQ8) was also synthesised.
All the peptides were synthesised in house using Novasyn TGA
resin (continuous £ow method) [15] and Wang 1 resin (batch method)
[16] on a Novabiochem and Advanced Chemtech ACT-90 peptide
synthesisers, respectively, using standard protocols of Fmoc chemistry
and puri¢ed by reversed phase high performance liquid chromatog-
raphy. The integrity of peptide sequences was established by auto-
mated peptide sequencing (Procise 491, Applied Biosystem) and
FABMS. The peptides synthetically obtained and studied were
Q8HQHQ8, Q10HQHQ10, Q8HQ4HQ8 and Q22.
2.2. Physicochemical investigations
Circular dichroism (CD) measurements were made on a Jasco J-710
spectropolarimeter equipped with Pelteir Thermo Controller (PTC)-
348. CD spectra reported are an average of 8^10 scans. All the pep-
tides were previously dissolved in pure water and aliquots of the
required amount were added to make samples of various concentra-
tions of peptides in 3.3 mM sodium chloride sodium citrate bu¡er,
pH = 7.2. All concentrations of peptides are calculated using per res-
idue molecular weight for uniformity. Due to insolubility of Q22,
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samples for a 8.7U1034 M/residue concentration were prepared by
adding 2% dimethyl sulfoxide (DMSO).
Solid phase FTIR spectra were recorded on a Perkin Elmer spec-
trum 1000 FTIR spectrometer, using KBr as medium. Deconvolution
and second derivative analysis of the spectra were carried out using
the software supplied by the manufacturer.
3. Results and discussion
Poly-L-glutamines are known to be insoluble in water and
even short oligoglutamine chains tend to aggregate [6,17].
Therefore, the aqueous solubility of Q8HQHQ8, Q10HQHQ10,
Q8HQ4HQ8 and Q22 peptides at di¡erent concentrations were
measured, by observing scattering, if any, at 320 nm in UV-vis
absorption and CD spectroscopy [18,19]. The results are col-
lated in Table 1. From the results (Table 1), it can clearly be
observed that Q8HQHQ8, Q10HQHQ10 and Q8HQ4HQ8, de-
spite being of comparable length, are more soluble than Q22.
Moreover, Q8HQHQ8 and Q10HQHQ10, where histidine in-
terruptions are separated by one glutamine, are 4^7 times
more soluble than Q8HQ4HQ8, where these interruptions
are separated by four glutamines. It appears that the insolu-
bility and aggregation phenomenon exhibited by these poly-
glutamine peptides are not just concentration or length de-
Fig. 1. CD spectra of polyglutamine peptides with and without histidine interruptions at various concentrations. (A) Q22, (B) Q8HQHQ8, (C)
Q10HQHQ10 and (D) Q8HQ4HQ8. The spectra shown in (B^D) indicate a conformational transition from low to high concentration of the pep-
tides. In contrast, the spectra in (A) do not show such a transition at di¡erent concentrations.
Fig. 2. CD spectra of 5.7U1034 M/residue of Q22 at di¡erent tem-
peratures suggest collapse of the L-structure at a high temperature
and formation of this structure is irreversible.
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pendent, but the histidine interruptions have a major role to
play in this regard. The reason for this di¡erential solubility
behaviour cannot be just the presence of histidine residues,
because as such, histidine residues are slightly more hydro-
phobic than glutamines at neutral pH [20]. Hence, it was
thought that these histidine-interrupted polyglutamine pepti-
des might be adopting di¡erent conformation(s) from Q22,
which in turn play a key role in determining their solubility
and aggregation properties.
CD spectra of Q22, Q8HQHQ8, Q10HQHQ10 and
Q8HQ4HQ8 peptides were measured at various concentrations
(Fig. 1A^D). The CD spectra of Q22, at all measured concen-
trations, exhibited a positive band at 202 nm and a negative
band around 222 nm. The molar ellipticity of both the bands
increased with an increase in peptide concentration up to
5.7U1034 M. These spectra resembled that of strongly twisted
and tightly linked wide intermolecular L-sheets which are
characterised by the large magnitude of the Z-Z* positive
band near 200 nm compared to the weak n-Z* negative
band centred around 220 nm, i.e. dvOZÿZ d/dvOnÿZ dV5^7 [21].
At higher concentrations, scattering was observed due to ag-
gregation of L-sheet structures (Fig. 1A), eventually leading to
precipitation. At low concentrations, His-interrupted peptides,
Q8HQHQ8, Q10HQHQ10 and Q8HQ4HQ8, exhibited a blue-
shifted positive CD band in the range 193^195 nm, suggesting
that L-sheets formed by these peptides do not involve more
than two to three strands and these structures are mostly
intramolecular in nature. Since the exciton component for
the Z-Z* positive CD band is directed along the H-bond di-
rection, the position of this band depends upon the width of
the sheet [22]. This band shifts to a longer wavelength (red-
shifted to 202 nm) at higher concentrations of Q8HQHQ8 (7
mM and above), Q10HQHQ10 (5 mM) and Q8HQ4HQ8 (1.4
mM) peptides. At these concentrations, Q22 is completely in-
soluble. This suggests that with an increasing concentration,
there is either widening of the existing intramolecular L-sheet
structure and/or formation of intermolecular species. From
Fig. 1, it can be observed that at similar concentrations, the
molar ellipticity of the positive band is more in case of Q22
compared to Q8HQ4HQ8sQ10HQHQ10sQ8HQHQ8 pepti-
des. This once again suggests that Q22 forms highly twisted
and tightly linked wide intermolecular L-sheets even at low
concentrations. Formation of L-sheets by polyglutamines via
Fig. 3. CD spectra of 7.0U1033 M/residue of Q10HQHQ10 at di¡er-
ent temperatures suggest melting of the L-structure at a high tem-
perature but the peptide regains approximately 60% of its native
structure on cooling at 30‡C for 24 h.
Fig. 4. Second derivative FTIR spectra (in KBr) of Q22 and
Q10HQHQ10. The similarity of these spectra suggests that in solid
phase, both uninterrupted and histidine-interrupted polyglutamine
peptides form aggregates of an intermolecular L-structure.
Table 1
Aqueous solubility of Q8HQHQ8, Q10HQHQ10, Q8HQ4HQ8 and Q22
Peptide concentration in M/residue Q8HQHQ8 Q10HQHQ10 Q8HQ4HQ8 Q22
1.4U1034 Soluble Soluble Soluble Soluble
No scattering No scattering No scattering No scattering
5.7U1034 Soluble Soluble Soluble Soluble
No scattering No scattering No scattering No scattering
8.7U1034 Soluble Soluble Soluble Soluble (2% DMSO)
No scattering No scattering No scattering Mild scattering
1.4U1033 Soluble Soluble Soluble Partly soluble
No scattering No scattering No scattering Scattering
7.0U1033 Soluble Soluble Partly soluble Insoluble
No scattering No scattering Mild scattering
1.0U1032 Soluble Partly soluble Partly soluble Insoluble
No scattering Mild scattering Scattering
1.2U1032 Partly soluble Insoluble Insoluble Insoluble
Mild scattering
5.0U1032 Partly soluble Insoluble Insoluble Insoluble
Scattering
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the polar zipper mechanism has been proposed by Perutz et
al. [6]. Moreover, the di¡erence between the Vmax of CD and
absorption spectra of Q22 was about 12 nm, compared to
Q8HQHQ8, Q10HQHQ10 and Q8HQ4HQ8 peptides where it
was only 5 nm, which also suggest that the Q22 adopts an
anti-parallel L-sheet conformation whereas others form paral-
lel and/or anti-parallel L-sheets. Our results are in accordance
with Woody’s predictions and theoretical calculations on anti-
parallel and parallel L-sheets [23].
From the solubility data (Table 1) and concentration de-
pendent CD pro¢les (Fig. 1), it can be concluded that in all
the polyglutamine peptides with or without histidine interrup-
tion(s), the insolubility and aggregation phenomena occur
only after the formation of large (wide) intermolecular L-sheet
structures. However, polyglutamine peptides with His inter-
ruptions undergo such an aggregation at much higher concen-
trations compared to uninterrupted polyglutamine tracts. In-
terrupted polyglutamine peptides with a HQH motif in the
middle as observed in normal SCA1 proteins showed the least
propensity to form large L-sheet structures and hence a lower
aggregation potential.
The CD pro¢les of Q22 (5.7U1034 M/residue) at di¡erent
temperatures are shown in Fig. 2. With an increasing temper-
ature, the molar ellipticity of both the positive band at 202 nm
and negative band at 220 nm decreased, indicating collapse of
the ordered L-structure. It was interesting to note that even
after cooling for 24 h at 30‡C, Q22 did not regain its native
conformation, suggesting formation of a disordered aggre-
gated structure, most likely involving main chain-side chain
hydrogen bonding. Such disordered aggregated structures
have been proposed to be responsible for neurodegenerative
diseases [6]. In contrast, all the histidine-interrupted peptides
at a high concentration regain about 60% of the native struc-
ture after complete thermal denaturation (CD pro¢le shown
only for Q10HQHQ10 at 7U1033 M/residue) (Fig. 3). The
histidine-interrupted peptides at low concentrations
(Q10HQHQ10 at 5.7U1034 M/residue) (data not shown) re-
gain almost the complete native structure on cooling at 30‡C
after 95‡C thermal denaturation. These results suggest that
peptides with histidine interruptions at a low concentration
form intramolecular L-hairpins which are reversibly folded
on renaturation (Fig. 5a). Denaturation at a higher concen-
tration causes partial non-speci¢c aggregation for these pep-
tides. Whereas Q22, even at a low concentration, does not
regain the native structure after denaturation as the native
structure is stabilised through ordered intramolecular hydro-
gen binding (Fig. 5b). On denaturation, random main chain-
side chain hydrogen bonding, as proposed by Pertuz et al. [6],
could be responsible for the formation of irreversible aggre-
gates. Since the conformational analysis of these peptides in a
solution phase at higher concentrations was di⁄cult because
of solubility and scattering problems, we carried out confor-
mational analysis of these in solid phase by recording second
derivative FTIR spectra in KBr. In all the peptides, the major
amide I peaks were in the 1604 þ 1 cm31, 1626 þ 2 cm31,
1659 þ 2 cm31 and 1691 þ 2 cm31 wavelength range (Fig. 4).
The band at 1658 þ 2 cm31 indicates presence of an anti-par-
allel orientation of L-strands [24], whereas the peaks at
1605 þ 1 cm31, 1626 þ 2 cm31 and 1691 þ 2 cm31 are mainly
due to aggregates of intermolecular L-structures [25^27].
Hence, in solid state, all the peptides seem to form aggregated
intermolecular L-structures.
Our results strongly suggest that the peptides containing a
polyglutamine stretch (with or without interruption(s)) at low
concentrations are soluble in water and exhibit L-structure
and not a random coil as suggested by Altschuler et al. [9].
Fig. 5. Schematic representation of (a) intramolecular L-sheet structure that is proposed to be formed by polyglutamine peptides interrupted
with the HQH motif. (b) Intermolecular L-sheet structure which is adopted by an uninterrupted polyglutamine tract.
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Our study also supports that the molecular basis of the dis-
ease may be formation of large aggregates as proposed by
Perutz et al. [6,28] and Subirana et al. [29]. Moreover, we
propose that the aggregation phenomenon is preceded by a
conformational change, i.e. aggregation takes place via the
formation of large intermolecular L-sheet structures (Fig. 5).
Therefore, the aggregation phenomenon is not only length
dependent but also depends upon the propensity to form large
intermolecular L-sheets. Histidine interruptions of the poly-
glutamine stretch seems to favour intramolecular L-hairpin
formation and reduces the potential to form large intermolec-
ular L-sheet structures and aggregation.
This study provides experimental evidence that polyglut-
amine tracts with His interruption(s) as observed in the nor-
mal SCA1 sequence are highly soluble and possess less aggre-
gation propensity, whereas uninterrupted polyglutamine tracts
exhibit a high aggregation potential even at low concentra-
tions. These peptide models also provide evidence about how
a point mutation with a change in amino acid(s) could bring
change in conformational properties and lead to aggregation
which may be responsible for the disease processes.
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